izpis_h1_title_alt

Evolution of diabetes technology
ID Dovč, Klemen (Author), ID Battelino, Tadej (Author)

.pdfPDF - Presentation file, Download (302,87 KB)
MD5: 314329F899C3B6B5067557D5A1E96A21
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S088985291930091X This link opens in a new window

Abstract
In view of the current accelerating pace of diabetes technology development, ever smaller and more accurate CGM sensors, novel implantable sensors for long-term use (>1 year) with no on-body components, and CGM devices with increased connectivity and improved data visualization both on the device and remotely through the cloud can be anticipated. Automated systems for insulin delivery will become more independent and will likely incorporate other physiologic and behavioral data for providing more accurate predictions, particularly related to food and physical activity. With the increasing technical complexity, DSSs will become an inevitable part of digital diabetes clinics, including their use at the primary care level. In addition, all will depend on the cost-effectiveness that will drive the access and reimbursement of different technologies, and ultimately on the acceptance of any particular technology by individuals with diabetes. TIR is being validated as a new clinical marker, and simple clinical guidance on TIR targets and data visualization were broadly endorsed by professionals, and are being introduced to individuals with diabetes. However, the ultimate goal of diabetes technology development remains clear: improved diabetes outcomes with reduced disease burden and increased QOL for all individuals with diabetes and their families.

Language:English
Keywords:artificial pancreas, type 1 diabetes, continuous glucose monitoring, insulin pump, technology, closed loop, self-monitoring of blood glucose, multiple daily injections
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2020
Number of pages:Str. 1-18
Numbering:Vol. 50, iss. 1
PID:20.500.12556/RUL-137774 This link opens in a new window
UDC:616.379
ISSN on article:0889-8529
DOI:10.1016/j.ecl.2019.10.009 This link opens in a new window
COBISS.SI-ID:6802092 This link opens in a new window
Publication date in RUL:30.06.2022
Views:452
Downloads:164
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Endocrinology and metabolism clinics of North America
Shortened title:Endocrinol. metab. clin. North Am.
Publisher:Elsevier
ISSN:0889-8529
COBISS.SI-ID:25392384 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back